EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RAS signalling in the colorectum in health and disease



RAS signalling in the colorectum in health and disease



Cell Communication & Adhesion 19(1): 1-9



RAS proteins act as molecular switches between several homeostatic inputs and signal transduction pathways that regulate important cellular processes including cell growth, differentiation and survival. Activating mutations change the function of normal proto-oncogenic RAS proteins to oncogenic RAS proteins that trigger a wide range of downstream effectors altering expression of transcription factors that together stimulate cell proliferation and modulate apoptosis and differentiation. RAS genes are amongst the most frequently mutated genes in human cancers, in particular KRAS is mutated in 40-50% of colorectal cancers. Mutation of this gene has a significant impact on treatment management and patients' survival, particularly in relation to anti-EGFR therapy, which is only effective in KRAS wild-type cases. Here, we discuss the regulation of KRAS signalling in the colorectum, some of the post-transcriptional and post-translational modifications that control its activity, the mutations and other DNA alterations that are found in this tumour type and the implications that they have for disease progression and current drug treatments.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333411

Download citation: RISBibTeXText

PMID: 22233291

DOI: 10.3109/15419061.2011.649380



Related references

Special issue--signalling. Introduction--Ca2+ signalling and transport in health and disease. Febs Journal 280(21): 5384-5384, 2013

Wnt signalling pathway in the serrated neoplastic pathway of the colorectum: possible roles and epigenetic regulatory mechanisms. Journal of Clinical Pathology 65(8): 675-679, 2012

Akt signalling in health and disease. Cellular Signalling 23(10): 1515-1527, 2011

Lipid signalling in health and disease. Febs Journal 280(24): 6280-6280, 2014

In brief: Notch signalling in health and disease. Journal of Pathology 232(1): 1-3, 2014

Neurotrophin signalling in health and disease. Clinical Science 110(2): 167-173, 2006

mTOR Signalling in Health and Disease. Biochemical Society Transactions 39(2): 431-436, 2011

Purinergic signalling in the liver in health and disease. Purinergic Signalling 10(1): 51-70, 2014

Renal purinergic signalling in health and disease. Acta Physiologica 213(4): 805-807, 2015

Insulin signalling to the kidney in health and disease. Clinical Science 124(6): 351-370, 2013

Purinergic signalling in the kidney in health and disease. Purinergic Signalling 10(1): 71-101, 2014

TLR4 signalling in the intestine in health and disease. Biochemical Society Transactions 35(Pt 6): 1473-1478, 2007

p130Cas: a key signalling node in health and disease. Cellular Signalling 25(4): 766-777, 2013

PKCθ-regulated signalling in health and disease. Biochemical Society Transactions 42(6): 1484-1489, 2015

Gastrointestinal peptide signalling in health and disease. European Journal of Surgery. Supplement. 587): 23-38, 2005